Stem Cell Therapy for Joint Pain: Can It Help Delay More Invasive Treatments?

If your knee aches on the stairs or your shoulder protests every time you reach overhead, the idea of surgery can feel like a heavy door you are not ready to open. That is often where curiosity about stem cell therapy for joint pain at The Re Clinic begins. 

Does Stem Cell Therapy for Joint Pain Delay More Invasive Treatments?

For some people with mild to moderate arthritis, stem cell therapy may ease pain and inflammation enough to postpone surgery for a time. But evidence does not confirm it reliably delays joint replacement, and the underlying wear usually continues. Think of it as possible comfort, not a guaranteed pause.

What Stem Cell Therapy for Joint Pain Actually Is

Stem cell therapy for joint pain involves injecting cells into a damaged joint to calm inflammation and ease arthritis symptoms. The cells are a type known clinically as mesenchymal stem cells, or MSCs. At The Re Clinic in Sandy, UT, the treatment is offered as Regenerative Cell Therapy and uses umbilical cord allograft tissue rather than cells taken from your own body.

Most people exploring this are dealing with osteoarthritis, the gradual “wear and tear” kind of joint damage, usually in the knee, hip, or shoulder. It is worth clearing up one common assumption: the idea that these injections regrow cartilage is not well established. 

The more likely benefit, based on current understanding, is a reduction in inflammation, which can translate to less pain and better movement for some people. That distinction matters when you are weighing whether this is the right step for you.

Where It Fits on the Joint Pain Treatment Ladder

Regenerative medicine for joint pain usually enters the picture partway along a fairly standard progression of care. Most joint pain treatment starts conservatively, then escalates only as needed:

• First, conservative care: physical therapy, weight management, activity changes, and anti-inflammatory medication.
• Next, in-office options like corticosteroid or hyaluronic acid injections.
• Finally, surgical options such as joint replacement, typically reserved for advanced cases.

Stem Cell Therapy in Sandy, UT, tends to be something people consider when that first tier has not been enough, but they are not ready or willing to move toward surgery. That is a completely understandable place to be. 

What is important to say plainly is that using it to delay surgery is a hope many patients bring to the treatment, not a proven, guaranteed outcome. Holding that expectation loosely will serve you well.

Improve Joint Mobility?

Here is the honest picture. As of 2026, no stem cell product is FDA-approved for any orthopedic or joint condition. Treatments like this are considered investigational, which is exactly why insurance does not cover them.

The research so far is genuinely mixed. Most studies have been small and short-term, and one of the better-known ones, the MILES study, found that stem cell injections performed about the same as a standard corticosteroid injection. 

A large, well-funded Phase III trial is now underway, but meaningful results are not expected until around 2028 to 2029. In the meantime, some patients report real improvement in pain and mobility, while others notice little change. 

Results vary widely from person to person, and true cartilage regeneration has not been demonstrated. None of this means the treatment is without value, but it does mean any honest conversation about it has to include a lot of “may” and “for some people.”

Can It Actually Delay Surgery?

This is the heart of the question, so here is the direct answer: there is no strong evidence that stem cell therapy reliably delays or prevents joint replacement. That said, the nuance is worth sitting with. 

For some people with mild to moderate arthritis, meaningful symptom relief can make daily life more comfortable and, in practical terms, may push back the point at which surgery feels necessary. That experience is real for the patients who have it. What it does not appear to do is change the underlying disease. 

Osteoarthritis generally continues to progress in the joint even when symptoms improve, so “buying time” through better comfort is not the same as halting or reversing the damage. Going in with that understanding helps you judge the outcome fairly, rather than feeling let down by an expectation the treatment was never positioned to meet.

Who Tends to Be Considered a Candidate

The people generally considered for this non-surgical joint pain treatment have mild to moderate osteoarthritis, symptoms that conservative care has not resolved, and a preference to explore options before surgery. If that sounds like you, it is a reasonable conversation to have.

Candidacy has limits, though. Advanced, “bone-on-bone” arthritis is where the evidence is weakest, and it is often not a good fit. Most importantly, whether you are a candidate is a medical judgment, not something to decide on your own from an article. 

It depends on imaging and a full evaluation. At The Re Clinic, that starts with a free consultation, and our MD may request an MRI or other records to understand your specific situation before recommending anything.

Alternatives to Joint Replacement Surgery 

Alternatives to joint replacement surgery are worth understanding before committing to a major procedure. Options generally move from least to most invasive:

• Conservative care: physical therapy to strengthen the muscles around the joint, weight management to reduce load, activity changes, and anti-inflammatory medication.
• In-office injections: corticosteroids or hyaluronic acid, which may ease symptoms for a time when conservative care is not enough.
• Regenerative options: PRP and stem cell therapy, which sit in an experimental tier with mixed evidence and no FDA approval for joints.

None of these reverse osteoarthritis, but for the right candidate they can improve joint mobility and comfort, potentially delaying surgery.

Common Questions

• Is stem cell therapy FDA-approved for joints? No. As of 2026, it remains investigational for orthopedic and joint use, which is why a written disclosure is required in Utah.
• Does it regrow cartilage? Evidence does not support true cartilage regeneration. Any relief people feel is more likely from reduced inflammation in the joint.
• How long might results last? It varies. Some people report benefit lasting a year or more, while others notice little change. More research is needed before anyone can predict this reliably.
• Does insurance cover it? Generally no, because it is considered experimental. Many clinics, including The Re Clinic, do accept HSA and FSA funds.

Ready When You Are

The Re Clinic in Sandy, UT offers regenerative cell therapy for people looking to understand every option before surgery. Their team walks you through the honest picture during a free consultation, imaging and all. If you are curious, explore non-surgical options for joint pain today and see whether it fits your goals.